AzTrials
AzTrials

Breast Cancer Related LymphedemaNCT06065423

Evaluation of Home Program and Telerehabilitation for the Treatment Process in Patients With Breast Cancer-Related Lymphedema

A study testing Manuel Lymphatic Drainage(MLD), Exercises in people with Breast Cancer Related Lymphedema and Telerehabilitation, run by Marmara University at 2 sites in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

During the Covid-19 pandemic, rehabilitation services for all patients were affected, and a term that was previously in use but gained popularity during the pandemic entered our vocabulary: 'Telerehabilitation'. Read more about this study

Who is it for?
Ages 18 to 75 years, women onlyHealthy volunteers can take part
What is being tested?
Manuel Lymphatic Drainage(MLD), Exercises
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
2 sitesTurkey (Türkiye)
Study dates
1 Sep 2021to 1 Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients who had undergone breast surgery at least 3 months ago
  • Had stage 1-2 lymphedema
  • Had upper extremity lymphedema associated with breast cancer

Who cannot join

  • Signs of infection such as lymphangitis, cellulitis, fungal infections
  • Those with documented lymph node metastases
  • Those with bilateral lymphedema
  • Those with other diseases affecting upper extremity functions
  • Those with a history of previous surgery related to the upper extremity

Trial locations and contacts

2 sites in 1 country.

Turkey (Türkiye)2 sites
  • Canan Şanal-Toprak

    Istanbul, 34899

  • Marmara University School of Medicine, Pendik Education and Research Hospital, Department of Physical Medicine and Rehabilitation

    Istanbul

Other trials in Turkey (Türkiye)

About this study

During the Covid-19 pandemic, rehabilitation services for all patients were affected, and a term that was previously in use but gained popularity during the pandemic entered our vocabulary: 'Telerehabilitation'. The purpose of our study is to evaluate the treatment process and adherence of patients undergoing telerehabilitation.

Read the detailed description

Our study is a randomized single-blind prospective study. Patients aged 18 to 75 years with stage 1-2 lymphedema associated with breast cancer and upper extremity lymphedema, who had undergone breast surgery at least 3 months prior, were included in the study. Group 1: Patients were given a brochure explaining the massage and exercises they should perform. They were periodically contacted by a physiotherapist and clinician to remind them of their tasks. Group 2: Patients underwent telerehabilitation exercises and massages three times a week guided by a physiotherapist and clinician, and on the remaining days, they continued their self-administered tasks. Patients were evaluated three times: before treatment, at weeks 5 and 8 after treatment. During each visit, patients' inter-limb volume difference, Quick DASH and Life Impact Scale scores, pain, tension, stiffness, and heaviness sensations were assessed.

Being tested
Manuel Lymphatic Drainage(MLD), Exercises
Medical subject headings
Breast Cancer Lymphedema

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Manuel Lymphatic Drainage(MLD), ExercisesOther

    MLD:It is a unique massage technique that uses specific hand movements to provide a gentle pumping effect on the skin.

    Massage movements follow the direction of lymph flow and produce rapid results. The aim of this method is to achieve maximum skin tightening effect with minimum pressure.

    Exercise, on the other hand, increases physical performance, improves body composition, and provides an increase in quality of life by providing acute and chronic reductions in fatigue. Both aerobic exercises and strengthening exercises have been found effective on physical performance. It shows that a mixed program consisting of components such as aerobics, strengthening, coordination and stretching can positively affect flexibility, pain and energy expenditure in breast cancer patients.

Study groups in NCT06065423
Study groupRoleWhat they receive
Telerehabilitation GroupExperimentalpatients received exercises and massages through TR three times a week, conducted by a physiotherapist and a clinician. They were encouraged to perform their exercises and wear compression garments on the remaining days. Prior to the program, patients or their relatives received training from physiotherapists regarding exercises and Manual Lymphatic Drainage (MLD). Patients or their relatives were informed about the Zoom program and were instructed to acquire the application online. Two physiotherapists and groups of five patients each were organized based on rehabilitation days and hours, and access to the Zoom link was provided.
Receives: Other: Manuel Lymphatic Drainage(MLD), Exercises
Home- Exercise GroupActive comparatorpatients were provided with a brochure explaining the massages and exercises they needed to perform. Additionally, they were contacted three times a week by a physiotherapist and a clinician to remind them of the treatments, assess the continuity and accuracy of the treatments, encourage them to perform the treatments correctly and consistently, and promote the wearing of compression garments.
Receives: Other: Manuel Lymphatic Drainage(MLD), Exercises

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Volume Measurements

    Arm measurement was measured with a tape measure at 4 cm intervals and calculated using the cone method in cm3

    Measured: Time Frame: Day 0

  2. Volume Measurements

    Arm measurement was measured with a tape measure at 4 cm intervals and calculated using the cone method in cm3

    Measured: Time Frame: 5 weeks

  3. Volume Measurements

    Arm measurement was measured with a tape measure at 4 cm intervals and calculated using the cone method in cm3

    Measured: Time Frame: 8 weeks

  4. Symptom Severity

    Shoulder pain, tightness, sensation of heaviness, and stiffness were evaluated using a numerical scale (1 to 10 points)

    Measured: Time Frame: Day 0

  5. Symptom Severity

    Shoulder pain, tightness, sensation of heaviness, and stiffness were evaluated using a numerical scale (1 to 10 points)

    Measured: Time Frame: 5 weeks

  6. Symptom Severity

    Shoulder pain, tightness, sensation of heaviness, and stiffness were evaluated using a numerical scale (1 to 10 points)

    Measured: Time Frame: 8 weeks

  7. Functionality

    Ouick Disabilities of the Arm, Shoulder and Hand (Quick DASH) questionnaire

    Measured: Time Frame: Day 0

  8. Functionality

    Ouick Disabilities of the Arm, Shoulder and Hand (Quick DASH) questionnaire

    Measured: Time Frame: 5 weeks

  9. Functionality

    Ouick Disabilities of the Arm, Shoulder and Hand (Quick DASH) questionnaire

    Measured: Time Frame: 8 weeks

  10. Efficacity

    Lymphedema Quality of Life Impact Scale

    Measured: Time Frame: Day 0

  11. Efficacity

    Lymphedema Quality of Life Impact Scale

    Measured: Time Frame: 5 weeks

  12. Efficacity

    Lymphedema Quality of Life Impact Scale

    Measured: Time Frame: 8 weeks

Secondary outcomes (4)
  1. Patient satisfaction with the treatment

    Responses were gathered on a scale of very satisfied - satisfied - somewhat satisfied - unsatisfied

    Measured: Time Frame: 5 weeks

  2. Patient satisfaction with the treatment

    Responses were gathered on a scale of very satisfied - satisfied - somewhat satisfied - unsatisfied

    Measured: Time Frame: 8 weeks

  3. patients were asked to compare their hand functionality to before the injury

    Responses were gathered on a scale of 'much better - somewhat better - same - somewhat worse - much worse

    Measured: Time Frame: 5 weeks

  4. patients were asked to compare their hand functionality to before the injury

    Responses were gathered on a scale of 'much better - somewhat better - same - somewhat worse - much worse

    Measured: Time Frame: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Oct 2023
  2. Study start1 Sep 2021
  3. Primary completion1 Sep 2022
  4. Study completion1 Jun 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06065423
Sponsor's protocol ID
09.2021.131
Status last verified
Sep 2023
First submitted
26 Sep 2023
Last updated
3 Oct 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Manuel Lymphatic Drainage(MLD), Exercises in people with Breast Cancer Related Lymphedema and Telerehabilitation, run by Marmara University at 2 sites in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Volume Measurements (time frame: Time Frame: Day 0). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Oct 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in